Capstone Therapeutics Corp. (CAPS)

Other OTC - Other OTC Delayed Price. Currency in USD

37.00

0.00

(0.00%)

As of 02:31PM EST. Market open.

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	37.00
Open	37.00
Bid	0.23 x 10000
Ask	0.29 x 10000
Day's Range	37.00 - 37.00
52 Week Range	35.00 - 37.50
Volume	25
Avg. Volume	8

Market Cap	5.832M
Beta (5Y Monthly)	0.46
PE Ratio (TTM)	28.03
EPS (TTM)	1.32
Earnings Date	Aug 13, 2019
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CAPS

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

CAPSTONE THERAPEUTICS CORPORATI
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We CoverIn this edition, Skyworks soars, Big Biopharma builds immunity to headwinds, and Baidu and the cloud; and Harmonic Drive Systems, Elekta, and Nabtesco.
Rating
Fair Value
Economic Moat
8 months agoMorningstar

All

ACCESSWIRE
Capstone Holding Corp. Announces Exercise Of Secured Debt And Interest Conversion Option By Majority Shareholder, BP Peptides, LLC
ALSIP, IL / ACCESSWIRE / June 21, 2022/Capstone Holding Corp. (OTCQB:CAPS) ("the Company")EXERCISE OF SECURED DEBT AND INTEREST CONVERSION OPTION; ISSUANCE OF 78,333 SHARES OF THE COMPANY'S COMMON STOCKOn June 15, 2022, BP Peptides, LLC ("Brookstone") exercised its right to convert $1,938,746 of accrued interest and debt from its Senior Secured Note(s) into 78,333 shares of the Company's Common Stock (exercise price of $24.

Advertisement

S&P 5004,050.78-19.78(-0.49%)

Dow 3034,028.15+50.07(+0.15%)

Nasdaq11,476.41-145.30(-1.25%)

Russell 20001,909.08-2.37(-0.12%)

Crude Oil79.04-0.64(-0.80%)

Gold1,943.50-2.10(-0.11%)

Capstone Therapeutics Corp. (CAPS)

Chart Events

Performance Outlook

Fair Value

Related Research

Capstone Holding Corp. Announces Exercise Of Secured Debt And Interest Conversion Option By Majority Shareholder, BP Peptides, LLC

S&P 500
4,050.78
-19.78(-0.49%)

Dow 30
34,028.15
+50.07(+0.15%)

Nasdaq
11,476.41
-145.30(-1.25%)

Russell 2000
1,909.08
-2.37(-0.12%)

Crude Oil
79.04
-0.64(-0.80%)

Gold
1,943.50
-2.10(-0.11%)